Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 3 a Y-line, followed by 5-fluorouracil (5-FU) 400 mg / m² intravenous bolus, followed by 5-FU 2400 mg / m² continuous intravenous infusion
Please pass captcha verification before submit form